Concepedia

Liam Hackett

LH

Statistics

Publications

5

Citations

142

H-Index

5

Active since

2018

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Liam Hackett is an author at Dana-Farber Cancer Institute specializing in medicine, bh3 profiling, and oncology.

Publications per year

2018–2023

5

Publications

5

Hyperphosphorylation of BCL-2 family proteins underlies functional resistance to venetoclax in lymphoid malignancies

Stephen Jun Fei Chong, Fen Zhu, Olga Dashevsky et al. · Journal of Clinical Investigation · 2023 · 43 citations · Full text

Medicine, Molecular Biology, Oncology +16

BH3 profiling identifies ruxolitinib as a promising partner for venetoclax to treat T-cell prolymphocytic leukemia

Charles Herbaux, Christoph Kornauth, Stéphanie Poulain et al. · Blood · 2021 · 37 citations · Full text

Medicine, Oncology, Pharmacology +11

Disrupted childhood: the cost of persuasive design

Beeban Kidron, Alexandra Evans, Jenny Afia et al. · Middlesex University Research Repository (Middlesex University Of London) · 2018 · 25 citations · Full text

Arts, Design, Psychology +5

Updated Results from a Multicenter, Phase 2 Study of Acalabrutinib, Venetoclax, Obinutuzumab (AVO) in a Population of Previously Untreated Patients with CLL Enriched for High-Risk Disease

Christine E. Ryan, Benjamin L. Lampson, Svitlana Tyekucheva et al. · Blood · 2022 · 23 citations

Medicine, Pharmacology, Pharmacotherapy +6

Hypomethylating agent decitabine sensitizes diffuse large B-cell lymphoma to venetoclax

Fen Zhu, Jennifer L. Crombie, Wei Ni et al. · Haematologica · 2023 · 14 citations · Full text

Medicine, Oncology, Pharmacology +15

1–5 of 5